Christopher K. Murray, CHIEF TECHNICAL OPERATIONS at Blueprint Medicines Corp (BPMC), sold 600 shares at $56.40 ($34K) on 2023-10-26, disclosed to the SEC on 2023-10-30.
Scheduled sale ($34k) by CHIEF TECHNICAL OPERATIONS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BPMC | SELL | 2024-03-01 | $500K | — | Filing → |
| BPMC | SELL | 2023-12-11 | $375K | — | Filing → |
| BPMC | SELL | 2023-12-06 | $43K | — | Filing → |